期刊文献+

不同降血糖方法对糖尿病肾脏病患者血糖及尿蛋白排泄率的影响 被引量:3

Effect of different blood glucose-lowering methods on blood glucose fluctuations and urine protein excretion rate in early-middle stage diabetic nephropathy
下载PDF
导出
摘要 目的 比较早期糖尿病肾脏病患者接受不同降血糖方法治疗后血糖波动及尿蛋白排泄率(UAER)情况,探讨该期患者应用胰岛素治疗对于病程进展的预防及治疗作用.方法 选择128例糖尿病肾脏病患者,入选时肾小球滤过率(GFR)处于慢性肾脏病(CKD)1~3期,分为A组60例、B组68例;分别给予胰岛素治疗和非胰岛素治疗,对治疗结果进行分析比较,评判不同降血糖方法的疗效及影响因素.结果 A组血糖漂移度较B组显著降低(P<0.05)A、B组UAER分别为(82.5±19.6)μg/min和(65.7±21.1) μg/min,2组比较有统计学差异(P<0.05).结论 应用胰岛素治疗能更好控制血糖水平,有效减缓肾脏病变进展速度,是预防及治疗糖尿病肾脏病的有效方法. Objective Compare the efficacy of different blood glucose-lowering methods on the blood glucose fluctuations and urine protein excretion rate in the early stage of diabetic nephropathy, and evaluate the preventive and therapeutic effect of insulin therapy on disease progression. Methods 128 patients with diabetic nephropathy at CKD 1-3 phases estimated by GFR were divided into two groups. Group A (n = 60) was given insulin therapy. Group B (n = 68) was given non-insulin treatment. The efficacy of different blood glucose-lowering methods and influencing factors were analyzed. Results The blood glucose excursion in group A was significantly lower than in group B (P〈0. 05). There was significant difference in UAER between two groups (P〈0.05). Conclusions Insulin therapy can control the level of blood glucose better and effectively slow the progress of kidney disease. Insulin therapy is an effective treatment for diabetic nephropathy.
作者 贺海东 余晨
出处 《临床肾脏病杂志》 2012年第1期26-27,共2页 Journal Of Clinical Nephrology
关键词 糖尿病 肾脏病 血糖 Diabetic rnellitus Nephrology Blood glucose
  • 相关文献

参考文献8

  • 1The diabetes control and complications Trial/Epidemiology of di abetes interventions and complications research group; Retinopa thy and nephropathy in patients with typel diabetes four years af ter a trial of in-tensive therapy. N Eng J Med, 2000,342: 381-389.
  • 2UK prospective diabetes study group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type2diabetes (UKPDS34). Lancet, 1998,352 : 854- 865.
  • 3UK prospective diabetes study group. Efficacy of atenolol and captopril in reducing risk of macrovascular complications in type 2 diabetes(UKPDS38). BMJ, 1998,317 : 713-720.
  • 4UK prospective diabetes study group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2diabetes(UKPDS33). Lancet, 1998,352 : 837-853.
  • 5陈纯娴,吴可贵,王中心,杨芳.强化降糖治疗对老年糖尿病肾病的影响[J].中国老年学杂志,2009,29(10):1305-1306. 被引量:4
  • 6章秋,潘天荣,何勇,陈明卫,胡红琳,王长江,杨明功.强化降糖治疗对2型糖尿病尿微量白蛋白的影响[J].安徽医科大学学报,2005,40(4):384-386. 被引量:3
  • 7江芳芳,胡玲,陆君,伍英,梅承艳,孙掌花,陶武斌.强化降糖降压治疗2型糖尿病微血管病变的前瞻性研究[J].实用临床医学(江西),2005,6(7):54-55. 被引量:3
  • 8李贤卓,赵蕾,卢水焕,李水晴,唐伟雄.老年糖尿病患者低血糖诱发异常心电图分析[J].中国糖尿病杂志,2008,16(2):107-109. 被引量:15

二级参考文献21

  • 1Plima CS,Botiini PV,Garlipp R,et al.Accuracy of the urinary albumin to creatinine ratio as preditor of albuminuria adultswith sickle cell disease[J].J Clin Pathol,2002;55(12):973-5.
  • 2UK Prospective Diabetes Study Group.Intensive blood-glucose control with suphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J].Lancet,1998;352(9131):837-53.
  • 3Chalmers J. Advance study: objectives, design and current status. Drugs,2003;63(1):39~44.
  • 4American Diabetes Association.Diabetic nephropathy. American Diabetes Association: Clinical practice recommendations. Diab Care(UKPDS 38),1998;21(1S):50S~3S.
  • 5UK Prospective Diabetes Study Group. Intensive blood-glucose control with suphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet,1998;352(9131):837~53.
  • 6United Kingdom Prospective Diabetes Study Group.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38[J].BMJ,1998,317:703~713.
  • 7Zhang L,Krzentowski G,Albert A,et al.Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control[J].Diabetes Care,2001,24:1 275~1 279.
  • 8庞华威.DM低血糖致心房纤颤一例[J].中国DM杂志,1995,3:109-109.
  • 9Isomma B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001,24 : 683-689.
  • 10Austin MA, Mykkanen L, kuusisto J, et al. Prospective study of small LDLs as a risk factor for non-insulin-dependent diabetes mellitus in elderly men and women. Circulation, 1995, 92: 1770-1778.

共引文献19

同被引文献28

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部